← brief for 2026-08-13 · Slowing decline

Calcimimetics and CaSR signaling in CKD-MBD: bone–immune–vascular crosstalk and therapeutic potential

Paper B Peer reviewed Small trial

Key takeaways

A systematic review of calcium-sensing receptor (CaSR) modulators for kidney disease. Results: no direct effect on glomerular filtration rate or proteinuria reported in these studies.

Who did this work

Cai-Mei Zheng (Taipei Medical University-Shuang Ho Hospital) · Hsuan-Chu Hsu (National Yang Ming Chiao Tung University) · Yi‐Chou Hou (Fu Jen Catholic University) · Chien-Lin Lu (Fu Jen Catholic University) · Jing-Quan Zheng (Fu Jen Catholic University) · Kuo-Cheng Lu (Tri-Service General Hospital)

Source

Paper · OpenAlex, CKD works · 2026-08-11
https://doi.org/10.3389/fimmu.2026.1912252